Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Other Accumulated Expenses: 2012-2016

Historic Other Accumulated Expenses for Agios Pharmaceuticals (AGIO) over the last 5 years, with Dec 2016 value amounting to $168,000.

  • Agios Pharmaceuticals' Other Accumulated Expenses rose 386.84% to $1.3 million in Q1 2017 from the same period last year, while for Mar 2017 it was $1.3 million, marking a year-over-year increase of 386.84%. This contributed to the annual value of $168,000 for FY2016, which is 87.21% down from last year.
  • As of FY2016, Agios Pharmaceuticals' Other Accumulated Expenses stood at $168,000, which was down 87.21% from $1.3 million recorded in FY2015.
  • Agios Pharmaceuticals' 5-year Other Accumulated Expenses high stood at $1.3 million for FY2015, and its period low was $65,000 during FY2012.
  • Its 3-year average for Other Accumulated Expenses is $641,333, with a median of $442,000 in 2014.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Other Accumulated Expenses soared by 215.71% in 2014, and later plummeted by 87.21% in 2016.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Other Accumulated Expenses stood at $65,000 in 2012, then spiked by 115.38% to $140,000 in 2013, then skyrocketed by 215.71% to $442,000 in 2014, then surged by 197.29% to $1.3 million in 2015, then crashed by 87.21% to $168,000 in 2016.